Supply and Support for Pathogen Inactivation Systems


Nhs Blood & Transplant

CPV: 33000000, Application Closing Date:

The system will be used to treat plasma imported from countries with a reduced risk of vCJD transmission.
Treated plasma will be used in the subsequent manufacture of paediatric and neonatal plasma components,
and single and pooled cryoprecipitate. Approximate volume is 24000 plasma units per annum.

  • Start Date: – End Date:
  • To apply for this job email your details to

    Apply using webmail: Gmail / AOL / Yahoo / Outlook

    Share On:

    Leave a Reply